New Medical Director Appointed at Cedars-Sinai Cancer in Beverly Hills

Hematologist/oncologist Kevin Scher, MD, MBA, an expert in patient-centric care with more than 10 years of experience on the Cedars-Sinai Cancer faculty, has been appointed medical director of Cedars-Sinai Cancer in Beverly Hills. In his new role, Scher will work with Cedars-Sinai Cancer and Cedars-Sinai Medical Network leadership to ensure the highest standard of care for cancer patients.

In addition to serving as medical director for Cedars-Sinai Cancer in Beverly Hills, Scher will co-chair the Patient-Centric High-Value Care Committee, which works to improve patient care, safety and experience while reducing unnecessary health system costs.

“Dr. Scher is a highly regarded oncologist who specializes in bridging the needs of clinical physicians and the academic enterprise at Cedars-Sinai Cancer,” said Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer and the PHASE ONE Distinguished Chair. “In his new role, he will work to maximize the resources and expertise at Cedars-Sinai Cancer in Beverly Hills so that it can continue providing patients with the highest-quality care and compassion.”

Scher joined Cedars-Sinai Cancer in 2013 as a hematologist/oncologist and most recently served as clinical co-chief in the Division of Hematology/Oncology.

He earned his bachelor’s degree from Princeton University, a master’s in business administration from Columbia Business School and a medical degree from New York University School of Medicine. He went on to complete an internal medicine internship and residency at UCLA and a hematology/oncology fellowship at City of Hope Comprehensive Cancer Center.

Scher said he specialized in oncology because he wanted to help cancer patients during a vulnerable time in their lives. He’s also energized by research that leads to innovative treatments that help patients live longer—and thrive.

“Oncology is rapidly evolving, and we are making tremendous progress in treating and curing disease,” Scher said. “Using new discoveries to improve patient outcomes is gratifying, and I’m excited that we can provide more leading-edge treatments than ever before to our patients.”

Scher has authored research on prostate cancer, head and neck cancers, and predictors of hospital readmission among older adults with cancer in peer-reviewed medical journals, including Journal of the National Comprehensive Cancer Network, ASCO publications and Journal of Oncology Practice.

“Every day, my team and I are motivated by the desire to improve our patients’ health and their lives by providing the best possible experience for them,” Scher said. “I’m excited about the opportunity to further enhance our ability to care for our patients, and to help chart a long-term vision for Cedars-Sinai Cancer in Beverly Hills and the overall cancer program.”

Read more on the Cedars-Sinai Blog: Couple Reflects on Shared Cancer Journey